Close Menu

NEW YORK (GenomeWeb) – BATM Advanced Communications, an Israeli firm focused on real-time technologies for networking and medical laboratories, has agreed to invest up to $30 million in Ador Diagnostics, BATM's joint venture with Gamida for Life.

The funds will go toward commercialization of Ador's NATlab reader, a point-of-care molecular diagnostics platform that uses microarray cartridges to enable sample-to-answer identification of specific infectious diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Seven individuals have been named to the President's Council of Advisors on Science and Technology, ScienceInsider reports.

Retraction Watch reports that a series of tweets led to expression of concern for a PLOS Genetics paper, a move the paper's authors disagree with.

Researchers have sequenced pumas from North and South America to enable better identification of inbreeding, Cosmos magazine reports.

In Nucleic Acids Research this week: ways to find cell death or proliferation signatures, Han Chinese population genome database, and more.

Oct
24
Sponsored by
Sunquest

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
13
Sponsored by
Agena Bioscience

This webinar will discuss advances in detecting MET and NTRK variants in tumor samples, which can help clinicians determine the appropriate therapy for cancer patients.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center  has implemented a new capture-based application to accurately assess myeloid malignancies   by detecting complex variants in challenging genes  in a single experiment.